Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease

Br J Haematol. 2022 Aug;198(4):e67-e70. doi: 10.1111/bjh.18317. Epub 2022 Jun 22.

Authors

Cindy Ursule-Dufait¹, Djaouida Bengoufa², Ioannis Theodorou², Camille Villesuzanne¹, Bertrand Arnulf¹

Affiliations

¹ Immuno-hematology Department, Saint-Louis Hospital, APHP.Nord/Université Paris Cité, Paris, France.
² Immunology Laboratory, Saint-Louis Hospital, APHP, Paris, France.

PMID: 35732557
DOI: 10.1111/bjh.18317

No abstract available

Keywords: Hevylite; cold agglutinin disease; heavy chain/light chain antibodies; protein electrophoresis; serum immunofixation.

Publication types

Letter

MeSH terms

Anemia, Hemolytic, Autoimmune* / diagnosis
Anemia, Hemolytic, Autoimmune* / therapy
Biomarkers
Humans
Immunoglobulin Light Chains
Paraproteinemias* / diagnosis

Substances

Biomarkers
Immunoglobulin Light Chains